|Day Low/High||35.39 / 35.64|
|52 Wk Low/High||26.96 / 36.05|
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, proudly supports results of an independent, randomised clinical trial 1 concluding that, in the patients studied, the use of the PICO Single Use...
The FTSE 100 lagged its counterparts on Thursday following a run of broker downgrades and after a stronger pound ate into FX gains for London's blue chips.
Investors should look at cheap, inflation-proof stocks, which could be very cheap.
When interest rates rise, these quality dividend growth stocks should weather the storm.
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, highlights three scientific symposia at World Union of Wound Health Societies (WUWHS) on 25-29 September 2016 in Florence, Italy.
The medical device company taps Jason Hannon, an 11-year company veteran, as its new president and COO, succeeding Patrick Miles, who was appointed vice chairman.
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, announces the publication of a new research paper showing how a comprehensive ulcer prevention programme which included the use of...
The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.
The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.
The medical device company is spending $350 million for the gynecology business of Smith & Nephew, and has agreed to invest in an Israeli spinal robotics company.
The embattled pharmaceutical company's move to bring in additional directors and file an overdue financial report did little to appease the markets.
Medical device company Stryker is paying $1.2 billion cash for defibrillator maker Physio-Control on the heels of spending $2.8 billion on disposable health care devices manufacturer Sage Products.
Kraft Heinz is the new king of the packaged-food aisle and ConforMis' shares can go higher, Cramer says.
A possible Greek deal and J&J, JPMorgan and Honeywell earnings, among many others, are on Cramer's calendar for next week.
European stocks rose on Tuesday after Greece offered concessions to its international creditors at an emergency summit, stoking hopes of a debt deal within the next two days.
TheStreet highlights 3 stocks pushing the health services industry higher today.
TheStreet highlights 3 stocks pushing the health care sector higher today.
Smith & Nephew (LSE:SN) (NYSE:SNN), the global medical technology business, announces the conclusion of the 6th International Negative Pressure Wound Therapy (NPWT) Expert Meeting.
After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.
TheStreet highlights 3 stocks pushing the health services industry lower today.
Here's why investors should avoid the stock of the British medical-device maker.
Stock futures post minor gains in a holiday-shortened Christmas Eve session Wednesday after bouncing to record highs a day earlier.
Shares of Smith & Nephew (SNN) surged in London but are down in pre-market trading in New York after it was reported that Stryker Corp. (SYK) plans a takeover offer.
With a short trading day on Christmas Eve, European investors are in unadventurous mood on Wednesday.
U.S. stock futures rise; the Dow tops 18,000; Stryker is planning a takeover offer for Smith & Nephew, a report says; NFL video clips to be shown on Facebook.